Qube Research & Technologies Ltd

Position in IMTX — Immatics N.V.

CIK 1729829 LONDON, X0

Position in IMTX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$3,609,036

+$2,062,092 QoQ

Shares Held

366,772

+148.9% QoQ

Ownership

0.268%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Qube Research & Technologies Ltd holds $2,030,593,180 across 187 Biotechnology names. IMTX ranks #87 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	838,187	$277,330,932
2	FOLD	AMICUS THERAPEUTICS, INC.	8,809,340	$127,383,056
3	ROIV	Roivant Sciences Ltd.	3,450,904	$95,590,040
4	RPRX	Royalty Pharma plc	1,524,511	$73,130,792
5	REGN	Regeneron Pharmaceuticals, Inc.	83,358	$64,405,725
6	AXSM	Axsome Therapeutics, Inc.	335,334	$56,678,152
7	RVMD	Revolution Medicines, Inc.	553,290	$53,807,452
8	CYTK	Cytokinetics Inc	779,446	$51,373,285

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$3,609,036	366,772	+148.9%	Shares	Sole	2026-05-15
2025-12-31	$1,546,944	147,328	-4.8%	Shares	Sole	2026-02-17
2025-09-30	$1,318,495	154,753	-45.3%	Shares	Sole	2025-11-14
2025-06-30	$1,520,807	282,678	-41.0%	Shares	Sole	2025-08-14
2025-03-31	$2,160,673	479,085	+157.6%	Shares	Sole	2025-05-15
2024-12-31	$1,322,175	185,960	+734.8%	Shares	Sole	2025-02-14
2024-06-30	$258,835	22,275	-90.1%	Shares	Sole	2024-08-14
2024-03-31	$2,363,782	224,908	+9087.4%	Shares	Sole	2024-05-14
2023-12-31	$25,777	2,448	—	Shares	Sole	2024-02-13
No filing history on record for this holder in this stock.